Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for prevention of colistin-induced nephrotoxicity
IRCT20200408046990N16Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in colistin-induced nephrotoxicity, sponsored by Mashhad University of Medical Sciences. Started Aug 2024; status: completed.
02
Drugs
melatonin
03
Conditions
colistin-induced nephrotoxicity
Beyond the preview
Go deeper on IRCT20200408046990N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200408046990N16.